Cosmetic composition for improving skin wrinkles based on salmon extract
A cosmetic composition using dual molecular weight PDRN, ultra-low molecular weight collagen, and 8-type hyaluronic acid addresses absorption and synergy issues, achieving effective wrinkle reduction, elasticity enhancement, and moisture retention.
Patent Information
- Application Number
- KR1020260000438
- Authority / Receiving Office
- KR · KR
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2026-01-02
- Publication Date
- 2026-11-11
- Estimated Expiration
- 2046-01-02
AI Technical Summary
Existing cosmetic compositions for improving skin wrinkles and enhancing elasticity face limitations due to insufficient skin absorption rates, uneven functional expression across skin layers, and a lack of synergy among ingredients like collagen, hyaluronic acid, and PDRN, leading to reduced efficacy and usability issues.
A cosmetic composition combining salmon extract-based dual molecular weight PDRN, ultra-low molecular weight collagen, and an 8-type hyaluronic acid complex, designed to penetrate and act stepwise across skin layers, enhancing absorption and stability.
The composition achieves improved skin absorption, sustained wrinkle reduction, enhanced elasticity, and long-lasting moisture retention through synergistic effects of the combined ingredients.
Abstract
Description
Technology Field
[0001] The present invention is a cosmetic composition for improving skin wrinkles based on salmon extract. More specifically, the present invention relates to a cosmetic composition for improving skin wrinkles and enhancing elasticity, comprising a salmon extract (PDRN) included in the form of sodium DNA. Background Technology
[0002] Existing cosmetic compositions for improving skin wrinkles and enhancing elasticity have faced the problem of exhibiting only limited effects in the epidermal layer due to their reliance primarily on single-functional ingredients or macromolecular-weight moisturizers. In particular, general collagen or single-molecular-weight hyaluronic acid cannot sufficiently penetrate the skin barrier due to their molecular structural characteristics, making it difficult to lead to actual improvement in the dermal layer; consequently, the limitation of insufficient perceived improvement in elasticity after product use has been continuously raised.
[0003] Furthermore, a significant number of existing functional compositions are primarily composed of high-molecular components, resulting in low skin absorption rates. While high concentrations were required to achieve long-term wrinkle improvement effects, this often led to usability issues such as increased viscosity, poor spreadability, and increased stickiness. Consequently, actual products faced structural limitations that made it difficult to strike a technical balance between ensuring efficacy and improving user experience.
[0004] Furthermore, PDRN (Polydeoxyribonucleotide), widely known for its skin regeneration and damage repair functions, has proven effective in the medical and cosmetic fields; however, since it has primarily been applied in cosmetic compositions in a single molecular weight form, it has failed to secure sufficient synergy in terms of skin penetration depth, stability, and the speed of efficacy onset. In particular, despite the fact that skin tissues require different molecular structures depending on the layer, existing technologies have lacked a segmented approach to this, resulting in limited effects for regeneration and elasticity improvement.
[0005] Furthermore, although the moisturizing depth, duration, and elasticity effects of hyaluronic acid vary significantly depending on its molecular weight, most existing commercially available formulations contain only a single or a few combinations of molecular weights, resulting in insufficient long-term moisture retention and moisture delivery efficiency across different skin layers. Consequently, there was a limitation in effectively addressing the complex aging phenomena of the skin exposed to various environmental factors.
[0006] As such, existing technologies failed to provide optimal synergistic effects in terms of improving skin wrinkles and enhancing elasticity because they could not integrally utilize the individual advantages of ingredients such as ultra-low molecular weight collagen, PDRN of various molecular weights, and multi-molecular weight hyaluronic acid. Furthermore, the lack of technology for stable combination of ingredients made it difficult to create compositions that satisfy functionality, absorption, and usability.
[0007] Therefore, there is a need for a new cosmetic composition that acts stepwise on the skin surface and dermis layer while ensuring high absorption rate and stability, and simultaneously maximizing wrinkle reduction, elasticity improvement, and moisture retention functions. To overcome the limitations of existing technologies, the present invention proposes a composition that can provide enhanced skin improvement effects by combining salmon extract-based dual molecular weight PDRN, ultra-low molecular weight collagen, and an 8-type hyaluronic acid complex. Prior art literature
[0008] Republic of Korea Registered Patent No. 10-1941819 (Published Jan. 23, 2019) Republic of Korea Registered Patent No. 10-2549572 (Published July 11, 2023) Republic of Korea Registered Patent No. 10-2784991 (Published March 18, 2025) Republic of Korea Registered Patent No. 10-2876252 (Published Oct. 27, 2025) Republic of Korea Published Patent No. 10-2025-0122266 (Published Aug. 13, 2025) The problem to be solved
[0009] The problem that the present invention aims to solve is to improve the insufficient skin absorption rate and limitations in functional expression observed in existing cosmetic compositions for wrinkle improvement. Conventional high molecular weight collagen or single molecular weight hyaluronic acid had a problem in that they could not sufficiently penetrate the skin barrier and therefore could not effectively act on the dermis layer.
[0010] Furthermore, since PDRN is often applied in a single molecular weight form, there was a limitation in that its regenerative effects varied by skin layer. Moreover, the use of high concentrations of functional ingredients led to issues such as reduced formulation stability and deteriorated user experience, making it difficult to simultaneously satisfy both efficacy and usability.
[0011] Accordingly, the present invention aims to provide a stable cosmetic composition that can simultaneously improve wrinkles, strengthen elasticity, and maintain moisture by combining a salmon extract-based dual molecular weight PDRN, ultra-low molecular weight collagen, and a complex of eight types of hyaluronic acid to increase absorption efficiency in each skin layer. means of solving the problem
[0012] According to one embodiment, a cosmetic composition for improving skin wrinkles and enhancing elasticity comprises: 40-75% by weight of purified water, 3-12% by weight of butylene glycol, 2-10% by weight of glycerin, 1-6% by weight of cetearyl alcohol, 1-5% by weight of shea butter, 0.5-3% by weight of cetearyl oliveate, 0.5-3% by weight of glyceryl stearate, 0.2-3% by weight of synthetic beeswax, 0.2-2% by weight of palmitic acid, 0.3-2% by weight of stearic acid, 0.3-2% by weight of PEG-100 stearate, 0.2-2% by weight of sorbitan stearate, 0.1-1% by weight of polysorbate 60, 0.1-1% by weight of ultra-low molecular weight collagen extract, and 0.1-1% by weight of Centella asiatica extract. The present invention provides a salmon extract-based cosmetic composition for improving skin wrinkles, comprising 0.01 to 0.1 wt% of salmon extract (PDRN), 0.05 to 0.5 wt% of an 8-type hyaluronic acid complex, 0.05 to 0.3 wt% of fragrance, and trace amounts of other ingredients including a moisturizer, a viscosity modifier, and an emulsifier.
[0013] The above salmon extract (PDRN) is included in the form of sodium DNA, and the above salmon extract (PDRN) is composed of a dual molecular weight fraction PDRN comprising a low molecular weight PDRN in the range of 5-50 kDa and a high molecular weight PDRN in the range of 100-1500 kDa, and the low molecular weight PDRN and the high molecular weight PDRN may be characterized by being composed in a composition ratio of 20:80 to 40:60.
[0014] The above ultra-low molecular weight collagen extract is a collagen extract having an average molecular weight of 200 Da to 300 Da, and the ultra-low molecular weight collagen extract, the low molecular weight PDRN, and the high molecular weight PDRN may be characterized by being composed in a composition ratio of 55 to 85 : 5 to 20 : 10 to 30.
[0015] The above 8 types of hyaluronic acid complex may be characterized by including sodium hyaluronate, hydrolyzed sodium hyaluronate, hydrolyzed hyaluronic acid, hyaluronic acid, potassium hyaluronate, sodium hyaluronate crosspolymer, hydroxypropyltrimonium hyaluronate, and sodium acetylated hyaluronate, thereby simultaneously providing skin surface moisturization and dermal layer moisture retention functions.
[0016] The above-mentioned 8-type hyaluronic acid complex may be characterized by being composed of 0.0125~0.125 wt% sodium hyaluronate, 0.0075~0.075 wt% hydrolyzed sodium hyaluronate, 0.005~0.05 wt% hydrolyzed hyaluronic acid, 0.0075~0.075 wt% hyaluronic acid, 0.0025~0.025 wt% potassium hyaluronate, 0.0075~0.075 wt% sodium hyaluronate crosspolymer, 0.005~0.05 wt% hydroxypropyltrimonium hyaluronate, and 0.0025~0.025 wt% sodium acetylated hyaluronate. Effects of the invention
[0017] The embodiments include salmon extract-based PDRN, ultra-low molecular weight collagen, and a complex of eight types of hyaluronic acid, thereby enabling gradual moisturization of the skin surface and retention of internal moisture, which can simultaneously provide wrinkle improvement and elasticity enhancement effects.
[0018] Since the examples include low molecular weight PDRN and high molecular weight PDRN as dual molecular weight fractions, they can utilize the penetration and action characteristics of different skin layers and can more stably induce the expression of skin recovery and wrinkle reduction effects compared to compositions containing single molecular weight PDRN.
[0019] Since the examples contain ultra-low molecular weight collagen with a low average molecular weight, skin absorption can be improved compared to general collagen, and can provide effects that contribute to improving skin elasticity and skin texture.
[0020] The examples include eight types of hyaluronic acid complexes having different molecular weights and structures, so they can contribute to improving moisturizing duration, moisture retention, and elasticity maintenance effects compared to a single hyaluronic acid-based composition.
[0021] The examples include PDRN, ultra-low molecular weight collagen, and a complex of eight types of hyaluronic acid in a specific range of compositional ratios, thereby inducing synergistic effects through interactions between the ingredients, and can comprehensively enhance wrinkle improvement, elasticity enhancement, and moisture retention functions compared to a composition that simply combines the same ingredients.
[0022] The embodiments can be configured so that functional ingredients are stably dispersed and mixed through a formulation structure including an emulsifier, a viscosity modifier, and an oil phase component, thereby ensuring formulation stability during storage and use and mitigating issues that impair the user experience.
[0023] Meanwhile, the effects according to the embodiments are not limited to those mentioned above, and other unmentioned effects will be clearly understood by those skilled in the art from the description below. Specific details for implementing the invention
[0024] Hereinafter, embodiments are described in detail with reference to the attached drawings. However, various modifications may be made to the embodiments, and thus the scope of the patent application is not limited or restricted by these embodiments. It should be understood that all modifications, equivalents, and substitutions to the embodiments are included within the scope of the rights.
[0025] Specific structural or functional descriptions of the embodiments are disclosed for illustrative purposes only and may be modified and implemented in various forms. Accordingly, the embodiments are not limited to the specific disclosed forms, and the scope of this specification includes modifications, equivalents, or substitutions that fall within the technical concept.
[0026] Terms such as "first" or "second" may be used to describe various components, but these terms should be interpreted solely for the purpose of distinguishing one component from another. For example, the first component may be named the second component, and similarly, the second component may be named the first component.
[0027] When it is stated that a component is "connected" to another component, it should be understood that it may be directly connected to or coupled with that other component, or that there may be other components in between.
[0028] The terms used in the embodiments are for illustrative purposes only and should not be interpreted as intended to be limiting. Singular expressions include plural expressions unless the context clearly indicates otherwise. In this specification, terms such as "comprising" or "having" are intended to indicate the existence of the features, numbers, steps, actions, components, parts, or combinations thereof described in the specification, and should be understood as not precluding the existence or addition of one or more other features, numbers, steps, actions, components, parts, or combinations thereof.
[0029] Unless otherwise defined, all terms used herein, including technical or scientific terms, have the same meaning as generally understood by those skilled in the art to which the embodiments pertain. Terms such as those defined in commonly used dictionaries should be interpreted as having a meaning consistent with their meaning in the context of the relevant technology, and should not be interpreted in an ideal or overly formal sense unless explicitly defined in this application.
[0030] The advantages and features of the present invention and the methods for achieving them will become clear by referring to the embodiments described below in detail together with the accompanying drawings. However, the present invention is not limited to the embodiments disclosed below but may be implemented in various different forms. These embodiments are provided merely to ensure that the disclosure of the present invention is complete and to fully inform those skilled in the art of the scope of the invention, and the present invention is defined only by the scope of the claims.
[0031] In the embodiments of the present invention, unless otherwise defined, all terms used herein, including technical or scientific terms, have the same meaning as generally understood by those skilled in the art to which the present invention pertains. Terms such as those defined in commonly used dictionaries should be interpreted as having a meaning consistent with their meaning in the context of the relevant technology, and should not be interpreted in an ideal or overly formal sense unless explicitly defined in the embodiments of the present invention.
[0032] The shapes, sizes, ratios, angles, numbers, etc. disclosed in the drawings for explaining embodiments of the present invention are exemplary, and therefore the present invention is not limited to the depicted details. Furthermore, in describing the present invention, if it is determined that a detailed description of related known technology may unnecessarily obscure the essence of the present invention, such detailed description is omitted. Where terms such as "includes," "has," or "is made up" are used in this specification, other parts may be added unless "only" is used. Where a component is expressed in the singular, it includes cases where it includes the plural unless specifically stated otherwise.
[0033] In interpreting the components, they are interpreted to include a margin of error even in the absence of a separate explicit statement.
[0034] The size and thickness of each component shown in the drawings are illustrated for convenience of explanation, and the present invention is not necessarily limited to the size and thickness of the illustrated components.
[0035] The features of each of the various embodiments of the present invention may be combined or combined with one another, either partially or wholly, and as will be fully understood by those skilled in the art, various technical interlocking and operation are possible, and each embodiment may be implemented independently of one another or together in an interlocking relationship.
[0036] According to one embodiment, a cosmetic composition for improving skin wrinkles and enhancing elasticity comprises: 40-75% by weight of purified water, 3-12% by weight of butylene glycol, 2-10% by weight of glycerin, 1-6% by weight of cetearyl alcohol, 1-5% by weight of shea butter, 0.5-3% by weight of cetearyl oliveate, 0.5-3% by weight of glyceryl stearate, 0.2-3% by weight of synthetic beeswax, 0.2-2% by weight of palmitic acid, 0.3-2% by weight of stearic acid, 0.3-2% by weight of PEG-100 stearate, 0.2-2% by weight of sorbitan stearate, 0.1-1% by weight of polysorbate 60, 0.1-1% by weight of ultra-low molecular weight collagen extract, and 0.1-1% by weight of Centella asiatica extract. The present invention provides a salmon extract-based cosmetic composition for improving skin wrinkles, comprising 0.01 to 0.1 wt% of salmon extract (PDRN), 0.05 to 0.5 wt% of an 8-type hyaluronic acid complex, 0.05 to 0.3 wt% of fragrance, and trace amounts of other ingredients including a moisturizer, a viscosity modifier, and an emulsifier.
[0037] The above salmon extract (PDRN) is included in the form of sodium DNA, and the above salmon extract (PDRN) is composed of a dual molecular weight fraction PDRN comprising a low molecular weight PDRN in the range of 5-50 kDa and a high molecular weight PDRN in the range of 100-1500 kDa, and the low molecular weight PDRN and the high molecular weight PDRN may be characterized by being composed in a composition ratio of 20:80 to 40:60.
[0038] The above ultra-low molecular weight collagen extract is a collagen extract having an average molecular weight of 200 Da to 300 Da, and the ultra-low molecular weight collagen extract, the low molecular weight PDRN, and the high molecular weight PDRN may be characterized by being composed in a composition ratio of 55 to 85 : 5 to 20 : 10 to 30.
[0039] The above 8 types of hyaluronic acid complex may be characterized by including sodium hyaluronate, hydrolyzed sodium hyaluronate, hydrolyzed hyaluronic acid, hyaluronic acid, potassium hyaluronate, sodium hyaluronate crosspolymer, hydroxypropyltrimonium hyaluronate, and sodium acetylated hyaluronate, thereby simultaneously providing skin surface moisturization and dermal layer moisture retention functions.
[0040] The above-mentioned 8-type hyaluronic acid complex may be characterized by being composed of 0.0125~0.125 wt% sodium hyaluronate, 0.0075~0.075 wt% hydrolyzed sodium hyaluronate, 0.005~0.05 wt% hydrolyzed hyaluronic acid, 0.0075~0.075 wt% hyaluronic acid, 0.0025~0.025 wt% potassium hyaluronate, 0.0075~0.075 wt% sodium hyaluronate crosspolymer, 0.005~0.05 wt% hydroxypropyltrimonium hyaluronate, and 0.0025~0.025 wt% sodium acetylated hyaluronate.
[0041] Detailed description of the composition and combination
[0042] Hereinafter, focusing on preferred embodiments of the present invention, the technical significance of each component described in the claims and combinations thereof will be explained in more detail. The present invention relates to a cosmetic composition comprising salmon extract-based PDRN, ultra-low molecular weight collagen, and a hyaluronic acid complex having a multi-molecular weight structure, configured to simultaneously achieve skin wrinkle improvement and elasticity enhancement effects.
[0043] The cosmetic composition according to the present invention is designed to act stepwise from the skin surface to the dermis layer by organically combining multiple active ingredients having different molecular weights and mechanisms of action, rather than relying on a single functional ingredient. Through this, problems such as limitations in skin absorption, uneven expression of functionality, and reduced moisturizing duration observed in existing compositions can be effectively improved.
[0044] In particular, the present invention utilizes PDRN, a nucleic acid component extracted from salmon testes or salmon-derived tissues, as a core active ingredient. While PDRN is known to have effects such as promoting skin cell regeneration, alleviating inflammation, and accelerating tissue recovery, existing technologies have applied it in a single molecular weight form, which limits the depth of skin penetration and the range of action. Accordingly, the present invention adopts a dual molecular weight structure mixing low-molecular-weight PDRN and high-molecular-weight PDRN to enable the simultaneous utilization of different action characteristics depending on the skin layer.
[0045] In addition, the present invention includes ultra-low molecular weight collagen with an average molecular weight in the range of 200 Da to 300 Da. The ultra-low molecular weight collagen has a significantly smaller molecular size compared to general collagen, resulting in excellent skin barrier permeability, and can contribute to the activation of fibroblasts in the dermis and improvement of elasticity. The application of such ultra-low molecular weight collagen effectively solves the problem of reduced absorption rate that was pointed out as an issue in existing collagen-based cosmetic compositions.
[0046] In addition, the present invention comprises a complex of eight types of hyaluronic acid having different molecular weights and chemical structures. Each hyaluronic acid component performs different roles, such as moisturizing the skin surface, forming a moisture storage layer, and inhibiting moisture evaporation, and their combination provides long-term moisture retention and elasticity improvement effects compared to a single hyaluronic acid composition.
[0047] As such, the cosmetic composition of the present invention simultaneously achieves complex effects of improving skin wrinkles, strengthening elasticity, and enhancing long-lasting moisture through a structure in which salmon extract-based PDRN, ultra-low molecular weight collagen, and a complex of eight types of hyaluronic acid are organically combined.
[0048] 1. Composition, Molecular Weight, Structure, and Functional Role of Salmon Extract (PDRN)
[0049] The salmon extract used in the present invention comprises nucleic acid components extracted from salmon testes or salmon-derived tissues, and includes PDRN (Polydeoxyribonucleotide) as a main component. The PDRN is a bio-derived substance composed of a polymer of deoxyribonucleotides and is known to be involved in skin tissue regeneration and cell activation.
[0050] In the present invention, the salmon extract is not limited to a single molecular weight structure but is applied as a dual molecular weight structure in which low molecular weight PDRN and high molecular weight PDRN are mixed. Low molecular weight PDRN has a relatively low average molecular weight, making it easy to penetrate the skin barrier. It rapidly reaches the epidermal layer and the upper dermal layer, where it can participate in cell regeneration signaling. On the other hand, high molecular weight PDRN remains on the skin surface or near the stratum corneum, forming a stable protective environment for a long time and playing a supporting role in the action of low molecular weight PDRN.
[0051] This dual molecular weight structure can expand the range of action across different skin layers compared to existing compositions using single molecular weight PDRN, and offers the advantage of maintaining skin regeneration and wrinkle-reducing effects more sustainably. In particular, the combination of low molecular weight PDRN and high molecular weight PDRN enables the simultaneous securing of both skin penetration speed and sustained action.
[0052] The salmon extract-based PDRN according to the present invention may be included in a range of 0.01% to 0.1% by weight relative to the total composition, and within this range, a balance of skin regeneration and wrinkle improvement effects and formulation stability can be ensured. Below the above range, the wrinkle improvement effect may not be sufficiently expressed, and above the above range, formulation stability may be reduced or the possibility of skin irritation may increase.
[0053] In addition, the mixing ratio of low molecular weight PDRN and high molecular weight PDRN can be set to a range of 20:80 to 40:60. Within this range, an excellent balance between skin absorption efficiency and duration of action can be maintained, whereas outside of this range, the function of low molecular weight or high molecular weight PDRN may be excessively biased, which may reduce the overall wrinkle improvement effect.
[0054] While salmon extract-based PDRN can exhibit skin regeneration effects on its own, in this invention, its effect is further enhanced by being combined with an ultra-low molecular weight collagen and a multi-molecular weight hyaluronic acid complex. In particular, PDRN acts complementarily with the collagen synthesis pathway and the moisture-retaining function of hyaluronic acid to contribute to the restoration of skin elasticity and the reduction of wrinkles.
[0055] In the present invention, the salmon extract may be applied to a cosmetic composition after undergoing extraction, purification, and concentration processes, and the extraction method may be enzymatic hydrolysis, hot water extraction, solvent extraction, or a combination thereof. Additionally, the purification process may include processes such as filtration, centrifugation, and molecular weight fractionation, through which the ratio of low molecular weight and high molecular weight PDRN can be controlled.
[0056] Meanwhile, salmon extract may be applied in salt or stabilized form as needed, and may undergo an additional purification process to minimize skin irritation. These processing steps may be modified in various ways within the scope of the technical concept of the present invention.
[0057] As such, the salmon extract-based PDRN of the present invention provides superior skin wrinkle improvement and elasticity enhancement effects compared to existing technologies through its molecular weight structure, content range, and combination with other active ingredients.
[0058] 2. Molecular Weight Characteristics of Ultra-Low Molecular Weight Collagen and Interaction with Salmon Extract-Based PDRN
[0059] The cosmetic composition according to the present invention is characterized by comprising ultra-low molecular weight collagen having an average molecular weight in the range of 200 Da to 300 Da. The ultra-low molecular weight collagen has a significantly smaller molecular size compared to commonly used high molecular weight collagen or low molecular weight collagen, allowing it to pass through the skin barrier more easily and efficiently reach the dermis layer.
[0060] Conventional collagen components have molecular weights of thousands of Da or higher and tend to remain primarily on the skin surface, often limiting their effects to temporary moisturization or film formation. In contrast, the ultra-low molecular weight collagen applied in this invention has an extremely low molecular weight, allowing it to penetrate the stratum corneum and directly contribute to the activation of fibroblasts within the dermis, thereby making a more substantial contribution to improving skin elasticity and alleviating wrinkles.
[0061] The ultra-low molecular weight collagen extract according to the present invention can be prepared by enzymatic decomposition or chemical hydrolysis of a collagen raw material, and, if necessary, can selectively include only collagen extracts with an average molecular weight in the range of 200 Da to 300 Da through a molecular weight fractionation process. This molecular weight range is set by simultaneously considering skin absorption and formulation stability, and if it falls outside the above range, a decrease in absorption efficiency or a change in the physical properties of the formulation may occur.
[0062] The ultra-low molecular weight collagen extract according to the present invention may be included in a range of 0.1% to 1% by weight relative to the total composition, and within this range, the skin elasticity improvement effect and formulation stability can be secured in balance. Below this range, the skin elasticity improvement effect by collagen may not be sufficiently expressed, and if it exceeds this range, problems such as increased formulation viscosity or reduced usability may occur.
[0063] In particular, the present invention exhibits a mutually complementary action by using an ultra-low molecular weight collagen extract and salmon extract-based PDRN in combination. The salmon extract-based PDRN may include low molecular weight PDRN and high molecular weight PDRN; the low molecular weight PDRN is advantageous for skin absorption and regeneration signaling, while the high molecular weight PDRN can support sustained action by forming a protective environment on the skin surface.
[0064] As described in the claims, according to a preferred embodiment, the ultra-low molecular weight collagen extract, the low molecular weight PDRN, and the high molecular weight PDRN may be composed in a composition ratio of 55 to 85: 5 to 20: 10 to 30. The composition ratio range is set by considering the balance between skin absorption, the creation of a regenerative environment, and the duration of action, so that the dermal elasticity-improving action of the ultra-low molecular weight collagen extract and the regenerative and maintenance actions of the low molecular weight and high molecular weight PDRN can be expressed in combination without mutual interference.
[0065] Specifically, when low molecular weight PDRN creates an environment for the proliferation and regeneration of skin cells, ultra-low molecular weight collagen extract can contribute to the formation of collagen networks and the stabilization of skin structure within that environment, while high molecular weight PDRN can support the sustained action of the active ingredients by forming a protective barrier near the skin surface or stratum corneum. As a result, the speed and duration of skin wrinkle reduction can be improved compared to compositions containing a single ingredient.
[0066] In addition, the present invention may further include conventional cosmetic bases such as hyaluronic acid, moisturizers, emulsifiers, thickeners, and stabilizers in addition to the combination of the core ingredients above, and these ingredients may assist in maintaining skin moisture, strengthening the skin barrier, and improving the user experience.
[0067] As such, the ultra-low molecular weight collagen extract according to the present invention provides a combination of skin regeneration, elasticity improvement, and wrinkle reduction effects through an organic combination with low molecular weight PDRN and high molecular weight PDRN, and exhibits superior functional effects compared to existing collagen-based cosmetic compositions.
[0068] 3. Composition and Role of the 8-Type Hyaluronic Acid Complex
[0069] The cosmetic composition according to the present invention is characterized by comprising an 8-type hyaluronic acid complex to simultaneously provide skin surface moisturization and dermal layer moisture retention functions. The 8-type hyaluronic acid complex comprises sodium hyaluronate, hydrolyzed sodium hyaluronate, hydrolyzed hyaluronic acid, hyaluronic acid, potassium hyaluronate, sodium hyaluronate crosspolymer, hydroxypropyltrimonium hyaluronate, and sodium acetylated hyaluronate.
[0070] Generally, the site of action and function of hyaluronic acid within the skin can vary depending on its molecular weight and structural form. Hyaluronic acid with relatively high molecular weight or cross-linked structures forms a moisturizing barrier on the skin surface and above the stratum corneum to inhibit water evaporation, whereas hydrolyzed or low molecular weight forms of hyaluronic acid penetrate the skin barrier more easily and perform moisture binding and retention functions below the stratum corneum or in the epidermal layer. Additionally, cationic hyaluronic acid derivatives can improve moisture retention and user experience by enhancing adsorption to the skin or stratum corneum.
[0071] In this invention, by comprehensively considering these characteristics and applying the above-mentioned eight types of hyaluronic acid in combination, immediate moisturization on the skin surface and an internal moisture retention environment are simultaneously secured. In particular, basic water-binding ability is imparted by sodium hyaluronate and hyaluronic acid, faster penetration and internal moisture supply functions are assisted by hydrolyzed sodium hyaluronate and hydrolyzed hyaluronic acid, and the formation of a moisturizing film on the skin surface and moisture retention can be improved by sodium hyaluronate crosspolymer. Additionally, hydroxypropyltrimonium hyaluronate can improve moisture retention and usability by increasing skin adhesion through its cationic functional groups, and sodium acetylated hyaluronate can contribute to long-term moisture retention by improving skin affinity. Potassium hyaluronate can act as an auxiliary component in terms of water binding and formulation stability.
[0072] As described in the claim, the 8 types of hyaluronic acid complex may be included in a range of 0.05% to 0.5% by weight relative to the total composition, and within this range, skin moisturization duration, formulation stability, and usability can be ensured in a balanced manner. Below this range, the skin surface moisturization and dermal layer moisture retention effects may not be sufficiently expressed, and above this range, an increase in formulation viscosity or a decrease in usability, such as stickiness upon application, may occur.
[0073] In addition, as described in the claim, the 8 types of hyaluronic acid complex may be composed of the following content ranges. That is, it may be included in the range of 0.0125~0.125 wt% sodium hyaluronate, 0.0075~0.075 wt% hydrolyzed sodium hyaluronate, 0.005~0.05 wt% hydrolyzed hyaluronic acid, 0.0075~0.075 wt% hyaluronic acid, 0.0025~0.025 wt% potassium hyaluronate, 0.0075~0.075 wt% sodium hyaluronate crosspolymer, 0.005~0.05 wt% hydroxypropyltrimonium hyaluronate, and 0.0025~0.025 wt% sodium acetylated hyaluronate. The content range of each of the above ingredients is set so that the functions of forming a moisturizing film on the skin surface, internal moisture binding, long-lasting moisturization, and improving user experience are expressed complementarily.
[0074] In particular, the 8-type hyaluronic acid complex according to the present invention exhibits a complementary action when used in combination with salmon extract (PDRN) and ultra-low molecular weight collagen extract. The stable moisture-retaining environment formed by the hyaluronic acid complex can assist in the creation of a skin regeneration environment by PDRN and the skin elasticity improvement action by ultra-low molecular weight collagen extract to be expressed more efficiently. As a result, the cosmetic composition according to the present invention can exhibit superior effects compared to a single moisturizing ingredient-based composition in terms of skin wrinkle reduction, elasticity improvement, and long-lasting hydration.
[0075] As such, the 8-type hyaluronic acid complex according to the present invention is a combination of ingredients designed to simultaneously provide skin surface moisturization and dermal layer moisture retention functions, and can provide a combination of skin wrinkle improvement and elasticity enhancement effects through an organic combination with salmon extract-based PDRN and ultra-low molecular weight collagen extract.
[0076] 4. Basic composition of Centella Asiatica extract and cosmetics and securing formulation stability
[0077] The cosmetic composition according to the present invention may further include Centella asiatica extract to complement the skin soothing and barrier strengthening functions. The Centella asiatica extract is a plant-derived extract containing bioactive components extracted from Centella asiatica, and is widely known as an effective ingredient for skin soothing, anti-inflammatory, and repairing damaged skin.
[0078] The Centella asiatica extract according to the present invention may be included in a range of 0.1% to 1% by weight relative to the total composition, and within this range, the effects of alleviating skin irritation, reducing skin stress caused by the external environment, and stabilizing the action environment of the active ingredient can be secured in a balanced manner. Below this range, the skin soothing effect of the Centella asiatica extract may not be sufficiently expressed, and if it exceeds this range, problems such as reduced formulation stability or reduced usability depending on skin type may occur.
[0079] In particular, the Centella asiatica extract according to the present invention exhibits complementary effects when used in combination with salmon extract-based PDRN, ultra-low molecular weight collagen extract, and an 8-type hyaluronic acid complex. The skin soothing and protective environment formed by the Centella asiatica extract can assist in the more stable expression of the skin regeneration action by PDRN, the skin elasticity improvement action by the ultra-low molecular weight collagen extract, and the moisture retention function by the hyaluronic acid complex. Accordingly, the cosmetic composition according to the present invention is applicable to various skin types, including sensitive skin.
[0080] Meanwhile, the cosmetic composition according to the present invention includes a basic composition of the cosmetic, including purified water, a moisturizer, an emulsifier, a fatty acid, and a wax component, in addition to the active ingredient, to ensure formulation stability and usability. As described in the claims, purified water is included in a range of 40 to 75 weight percent relative to the total composition and can serve as a basic solvent for the formulation, while butylene glycol and glycerin are included in ranges of 3 to 12 weight percent and 2 to 10 weight percent, respectively, to assist in skin moisturization and dispersion stability of the active ingredient.
[0081] In addition, emulsifiers and oil phase components such as cetearyl alcohol, shea butter, cetearyl oliveate, glyceryl stearate, synthetic beeswax, palmitic acid, stearic acid, PEG-100 stearate, sorbitan stearate, and polysorbate 60 may each be included within the content ranges specified in the claims, thereby forming a stable emulsion formulation in which the active ingredient is uniformly dispersed. These formulation components enable application in various formulation forms such as creams, lotions, and emulsions.
[0082] The basic composition of the cosmetic according to the present invention is established by considering the interaction with salmon extract-based PDRN, ultra-low molecular weight collagen extract, and an 8-type hyaluronic acid complex, thereby inhibiting precipitation, separation, or denaturation of the active ingredients and maintaining a stable formulation for a long period. In addition, fragrance may be included in a range of 0.05 to 0.3 weight percent relative to the total composition, and can be adjusted to enhance the sensory satisfaction of the user without affecting the action of the active ingredients.
[0083] As such, the basic composition of the Centella asiatica extract and cosmetic according to the present invention is configured to support the function of the core active ingredient and simultaneously ensure formulation stability and usability, thereby contributing to increasing the practical applicability of a salmon extract-based cosmetic composition for improving skin wrinkles.
[0084] 5. Method for preparing the composition of the present invention
[0085] The cosmetic composition of the present invention can be prepared as an O / W emulsion formulation, for example, by the following process. First, for the aqueous phase, glycerin and butylene glycol are added to purified water and heated to 70°C to 75°C while stirring to dissolve them uniformly, and if necessary, a viscosity modifier or a humectant is added to form an aqueous base. Separately, for the oil phase, cetearyl alcohol, shea butter, cetearyl oliveate, glyceryl stearate, synthetic beeswax, palmitic acid, stearic acid, and PEG-100 stearate are mixed and then heated to 70°C to 75°C to completely melt them. Subsequently, emulsification is carried out by slowly adding the oil phase to the aqueous phase while performing high-speed stirring or homogenization. Once emulsification is complete, sorbitan stearate and polysorbate 60 can be added while cooling to 45°C to 50°C to reinforce emulsion stability. Next, at 40°C or below, heat-sensitive active ingredients such as salmon extract-based PDRN, ultra-low molecular weight collagen extract, an 8-type hyaluronic acid complex, and Centella asiatica extract are sequentially added and uniformly dispersed by low-speed stirring. Finally, after adding a fragrance, the product can be manufactured into a finished product through a degassing process. The above process conditions may be varied in terms of stirring speed, addition order, and heating / cooling temperature ranges without departing from the technical concept of the present invention.
[0086] The embodiments of the present invention are intended to exemplarily describe specific embodiments of a cosmetic composition comprising salmon extract-based PDRN, ultra-low molecular weight collagen extract, and a complex of eight types of hyaluronic acid. In particular, the embodiments are set around a compositional structure capable of simultaneously achieving skin wrinkle improvement, elasticity enhancement, and moisture retention effects, and the purpose is to clearly demonstrate that the cosmetic composition according to the present invention can be applied as an actual cosmetic formulation.
[0087] The embodiments presented below are merely examples to explain the technical concept of the present invention more specifically, and the scope of protection of the present invention is not limited thereto and may be modified and implemented in various forms within the scope of the claims.
[0088] <Example 1>
[0089] Cosmetic composition of the basic composition according to the present invention
[0090] Example 1 is a representative embodiment of a salmon extract-based cosmetic composition for improving skin wrinkles according to the present invention, and is a cosmetic composition having a basic composition comprising salmon extract-based PDRN, ultra-low molecular weight collagen extract, an 8-type hyaluronic acid complex, and Centella asiatica extract. This example is implemented as a typical emulsion formulation in the form of a cream or emulsion. The specific compositional ingredients and their contents are as described in Example 1 of [Table 1].
[0091] <Example 2>
[0092] Cosmetic composition with modified PDRN composition ratio (low molecular weight 40% : high molecular weight 60%)
[0093] In Example 2, the total content of salmon extract (PDRN) was maintained the same as in Example 1, while the compositional ratio of low molecular weight PDRN to high molecular weight PDRN was adjusted to 40:60 to form a cosmetic composition. The compositional components and their contents were set within the same range as in Example 1, as described in Example 2 of [Table 1].
[0094] <Example 3>
[0095] Cosmetic composition with a hyaluronic acid complex content applied close to the upper limit
[0096] In Example 3, a cosmetic composition was prepared by increasing the content of the 8-type hyaluronic acid complex compared to Example 1 (setting it close to the upper limit) while maintaining the other compositional components as they were. The specific compositional components and their contents are as described in Example 3 of [Table 1].
[0097] <Comparative Example 1>
[0098] Composition containing single molecular weight PDRN
[0099] In Comparative Example 1, the total content of salmon extract (PDRN) was maintained the same as in Example 1, but the cosmetic composition was prepared by constituting 0.08 wt% of salmon extract (PDRN) using only high molecular weight PDRN (100–1500 kDa) of a single molecular weight fraction, without including low molecular weight PDRN. The other compositional components and their contents were set the same as in Example 1, as described in Comparative Example 1 of [Table 1].
[0100] <Comparative Example 2>
[0101] Composition excluding PDRN
[0102] In Comparative Example 2, a cosmetic composition was prepared by excluding 0.08 wt% of salmon extract (PDRN) from the composition of Example 1. The difference in content resulting from the exclusion of salmon extract (PDRN) was corrected with purified water or other ingredients to make the total 100 wt%, and the other compositional ingredients and their contents were maintained within the same range as Example 1, as described in Comparative Example 2 of [Table 1].
[0103] <Comparative Example 3>
[0104] Composition excluding ultra-low molecular weight collagen
[0105] In Comparative Example 3, a cosmetic composition was prepared by excluding 0.30 wt% of ultra-low molecular weight collagen extract from the composition of Example 1. The difference in content resulting from the exclusion of the ultra-low molecular weight collagen extract was corrected with purified water or other ingredients, and other compositional ingredients and content were maintained within the same range as Example 1, as described in Comparative Example 3 of [Table 1].
[0106] <Comparative Example 4>
[0107] A composition containing only a single hyaluronic acid instead of an 8-type hyaluronic acid complex
[0108] In Comparative Example 4, a cosmetic composition was prepared by not including the 8-type hyaluronic acid complex from the composition of Example 1, but by including only 0.20 wt% of sodium hyaluronate, a single hyaluronic acid component. Accordingly, the remaining components constituting the 8-type hyaluronic acid complex were not included, and the compositional components and their contents were maintained within the same range as Example 1, as described in Comparative Example 4 of [Table 1].
[0109] Table of Compositions of Examples and Comparative Examples (Unit: weight%) composition Example 1 Example 2 Example 3 Comparative Example 1 Comparative Example 2 Comparative Example 3 Comparative Example 4 purified water 59.67 59.67 59.37 59.67 59.75 59.97 59.67 Butylene glycol 7.00 7.00 7.00 7.00 7.00 7.00 7.00 glycerin 5.00 5.00 5.00 5.00 5.00 5.00 5.00 cetearyl alcohol 3.00 3.00 3.00 3.00 3.00 3.00 3.00 Shea butter 3.00 3.00 3.00 3.00 3.00 3.00 3.00 Cetearyl Oliveate 1.50 1.50 1.50 1.50 1.50 1.50 1.50 Glyceryl stearate 1.50 1.50 1.50 1.50 1.50 1.50 1.50 synthetic beeswax 1.00 1.00 1.00 1.00 1.00 1.00 1.00 palmitic acid 0.80 0.80 0.80 0.80 0.80 0.80 0.80 Stearic acid 0.80 0.80 0.80 0.80 0.80 0.80 0.80 PEG-100 Stearate 1.00 1.00 1.00 1.00 1.00 1.00 1.00 Sorbitan stearate 0.50 0.50 0.50 0.50 0.50 0.50 0.50 Polysorbate 60 0.30 0.30 0.30 0.30 0.30 0.30 0.30 Ultra-low molecular weight collagen extract 0.30 0.30 0.30 0.30 0.30 - 0.30 salmon extract Low molecular weight PDRN 0.024 0.032 0.024 - - 0.024 0.024 Polymer PDRN 0.056 0.048 0.056 0.08 - 0.056 0.056 8-Type Hyaluronic Acid Complex 0.20 0.20 0.50 0.20 0.20 0.20 - Single hyaluronic acid (sodium hyaluronate) - - - - - - 0.20 Centella asiatica extract 0.50 0.50 0.50 0.50 0.50 0.50 0.50 spices 0.10 0.10 0.10 0.10 0.10 0.10 0.10 Other moisturizers, viscosity modifiers, and emulsifiers Remaining amount Remaining amount Remaining amount Remaining amount Remaining amount Remaining amount Remaining amount total 100.00 100.00 100.00 100.00 100.00 100.00 100.00
[0110] <Experimental Example 1>
[0111] Moisture retention evaluation
[0112] In Experimental Example 1, the moisture retention capacity of the compositions of Examples 1 to 3 and Comparative Examples 1 to 4 over time after application was compared using a stratum corneum moisture content measuring device. As a result, Examples 1 to 3 showed a significant increase in moisture content compared to before application at 1 hour of application, and the increased moisture content tended to be maintained relatively stably at 4, 8, and 24-hour intervals. In particular, Example 3, which applied the 8-type hyaluronic acid complex content close to the upper limit, maintained the largest increase in moisture content (Δmoisture content) compared to before application even at the 24-hour mark, demonstrating an excellent tendency in terms of long-term moisture retention. On the other hand, Comparative Example 1, containing only single molecular weight PDRN; Comparative Example 2, excluding PDRN; Comparative Example 3, excluding ultra-low molecular weight collagen; and Comparative Example 4, containing only a single hyaluronic acid instead of the 8-type hyaluronic acid complex, showed a tendency for reduced moisture retention capacity at the 24-hour mark compared to the Examples, as the initial increase in moisture was relatively low or the decrease over time was significant.
[0113] Moisture retention evaluation results (Stratum corneum moisture content; Corneometer arbitrary unit, mean ± standard deviation, n=10, application amount: 2 mg / cm², application site: inner forearm, notation: "Δmoisture content" = increase compared to before application (0 h)) division 0h 1h 4h 8h 24h Example 1 stratum corneum moisture content 32.1±3.0 52.6±4.2 46.1±4.0 41.0±3.6 36.2±3.2 Δmoisture content - +20.5 +14.0 +8.9 +4.1 Example 2 stratum corneum moisture content 32.0±2.8 53.4±4.1 47.3±4.0 42.3±3.7 36.8±3.1 Δmoisture content - +21.4 +15.3 +10.3 +4.8 Example 3 stratum corneum moisture content 32.2±3.1 56.8±4.5 51.9±4.3 47.3±4.0 40.1±3.5 Δmoisture content - +24.6 +19.7 +15.1 +7.9 Comparative Example 1 stratum corneum moisture content 32.0±3.0 48.4±4.0 40.2±3.8 36.5±3.4 33.6±3.2 Δmoisture content - +16.4 +8.2 +4.5 +1.6 Comparative Example 2 stratum corneum moisture content 32.1±2.9 45.9±3.8 38.6±3.6 35.1±3.3 33.2±3.1 Δmoisture content - +13.8 +6.5 +3.0 +1.1 Comparative Example 3 stratum corneum moisture content 32.2±3.0 47.1±3.9 39.3±3.7 35.8±3.4 33.4±3.2 Δmoisture content - +14.9 +7.1 +3.6 +1.2 Comparative Example 4 stratum corneum moisture content 32.0±2.8 49.0±4.1 41.5±3.9 37.8±3.6 34.1±3.3 Δmoisture content - +17.0 +9.5 +5.8 +2.1
[0114] <Experimental Example 2>
[0115] Comparison of elasticity improvement
[0116] In Experimental Example 2, the compositions of Examples 1 to 3 and Comparative Examples 1 to 4 were repeatedly applied to skin areas under the same conditions for a certain period, and the elasticity improvement effect was compared and evaluated by measuring the change in elastic recovery force (R2) using a Cutometer. Each measurement value was expressed as the mean value and standard deviation of the results of repeated measurements (n=10) on multiple test subjects under the same conditions. As a result, Examples 1 to 3 showed a tendency for skin elasticity to continuously improve, with R2 values significantly increasing compared to before application after both 2 and 4 weeks of application. In particular, Example 3 exhibited the highest elastic recovery force (R2) value and increase in elasticity (Δelasticity) at all measurement points, confirming that it has the best skin elasticity improvement effect when used for a long period. On the other hand, Comparative Examples 1 to 4 showed a tendency for lower skin elasticity improvement effects compared to the Examples under the same conditions, as the increase in elastic recovery force was relatively limited.
[0117] Skin elasticity improvement evaluation results (Elasticity recovery (R2), mean ± standard deviation, n=10, application amount: 2 mg / cm², application site: inner forearm) division Before application 2 weeks later 4 weeks later Example 1 Elastic restoring force (R2) 0.68±0.05 0.74±0.05 0.79±0.06 ΔElasticity - 0.06 0.11 Example 2 Elastic restoring force (R2) 0.69±0.05 0.76±0.06 0.82±0.06 ΔElasticity - 0.07 0.13 Example 3 Elastic restoring force (R2) 0.68±0.06 0.78±0.06 0.85±0.07 ΔElasticity - 0.1 0.17 Comparative Example 1 Elastic restoring force (R2) 0.69±0.05 0.72±0.05 0.75±0.06 ΔElasticity - 0.03 0.06 Comparative Example 2 Elastic restoring force (R2) 0.68±0.05 0.71±0.05 0.74±0.06 ΔElasticity - 0.03 0.06 Comparative Example 3 Elastic restoring force (R2) 0.69±0.06 0.73±0.06 0.76±0.07 ΔElasticity - 0.04 0.07 Comparative Example 4 Elastic restoring force (R2) 0.68±0.05 0.72±0.05 0.76±0.06 ΔElasticity - 0.04 0.08
[0118] <Experimental Example 3>
[0119] Wrinkle improvement evaluation
[0120] In Experimental Example 3, the compositions of Examples 1 to 3 and Comparative Examples 1 to 4 were repeatedly applied to skin areas under the same conditions for a certain period, and changes in wrinkle depth were measured using an optical 3D skin image analyzer (Primos CR). At this time, the initial wrinkle depth was set to '0', and the evaluation criteria were established by measuring the wrinkle depth reduction rate (%). Each measurement value was expressed as the mean value and standard deviation of the results of repeated measurements (n=10) on multiple test subjects under the same conditions. As a result, Examples 1 to 3 showed a tendency for gradual improvement in wrinkles, with the wrinkle depth reduction rate increasing significantly compared to before application after both 2 and 4 weeks of application. In particular, Example 3 showed the highest wrinkle depth reduction rate at all measurement points, confirming that it has the best wrinkle improvement effect with long-term use. On the other hand, Comparative Examples 1 to 4 showed a tendency for lower wrinkle improvement effects compared to the Examples under the same conditions, as the increase in the wrinkle depth reduction rate was relatively limited.
[0121] Wrinkle Improvement Evaluation Results (Wrinkle Depth Reduction Rate (%), Mean ± Standard Deviation, n=10, Application Amount: 2 mg / cm², Application Site: Eye Area, Measurement Equipment: Primos CR) division Before application 2 weeks later 4 weeks later Example 1 0.00±0.00 12.4±3.1 21.6±3.8 Example 2 0.00±0.00 14.8±3.4 24.9±4.1 Example 3 0.00±0.00 18.9±3.7 31.5±4.6 Comparative Example 1 0.00±0.00 7.2±2.8 12.6±3.2 Comparative Example 2 0.00±0.00 6.4±2.6 11.3±3.0 Comparative Example 3 0.00±0.00 8.1±2.9 14.2±3.4 Comparative Example 4 0.00±0.00 9.3±3.0 15.6±3.6
[0122] <Experimental Example 4>
[0123] Formulation stability evaluation
[0124] In Experimental Example 4, the formulation stability of the compositions of Examples 1 to 3 and Comparative Examples 1 to 4 was evaluated under storage conditions for a certain period. The formulation stability evaluation was performed based on changes in appearance (color change, occurrence of turbidity or precipitation), the occurrence of phase separation, and changes in viscosity. As a result, Examples 1 to 3 showed no changes in appearance or phase separation during a 12-week storage period, and the change in viscosity remained within ±6% of the initial value, confirming excellent formulation stability. In particular, Example 3 showed the most stable trend across all evaluation criteria. On the other hand, Comparative Examples 1 and 2 exhibited turbidity and precipitation, as well as phase separation, as the storage period progressed, and the range of viscosity change also increased significantly. Furthermore, Comparative Examples 3 and 4 also showed changes in appearance and viscosity upon long-term storage, exhibiting a tendency for relatively lower formulation stability compared to the Examples under the same conditions.
[0125] Formulation stability evaluation results (Storage conditions: airtight container, visual observation and evaluation of physical property changes for each condition) division beginning 4 weeks 8 weeks 12 weeks Example 1 Appearance (Color / Sedimentation) No issues No issues No issues No issues Phase separation doesn't exist doesn't exist doesn't exist doesn't exist Viscosity change standard ±3% ±5% ±6% Example 2 Appearance (Color / Sedimentation) No issues No issues No issues No issues Phase separation doesn't exist doesn't exist doesn't exist doesn't exist Viscosity change standard ±2% ±4% ±5% Example 3 Appearance (Color / Sedimentation) No issues No issues No issues No issues Phase separation doesn't exist doesn't exist doesn't exist doesn't exist Viscosity change standard ±2% ±3% ±4% Comparative Example 1 Appearance (Color / Sedimentation) No issues Slight turbidity muddiness Precipitation Phase separation doesn't exist weak Partial occurrence generation Viscosity change standard ±7% ±12% ±18% Comparative Example 2 Appearance (Color / Sedimentation) No issues Slight turbidity muddiness Precipitation Phase separation doesn't exist weak Partial occurrence generation Viscosity change standard ±8% ±13% ±20% Comparative Example 3 Appearance (Color / Sedimentation) No issues No issues Slight turbidity muddiness Phase separation doesn't exist doesn't exist weak Partial occurrence Viscosity change standard ±6% ±10% ±14% Comparative Example 4 Appearance (Color / Sedimentation) No issues No issues Slight turbidity muddiness Phase separation doesn't exist doesn't exist weak Partial occurrence Viscosity change standard ±6% ±9% ±13%
[0126] conclusion
[0127] An overall improved trend may be observed in the indicators of elasticity improvement and wrinkle reduction. In particular, in the case of Comparative Example 1, which applied only single molecular weight PDRN, the balance of the range of action and duration of action by skin layer may be relatively reduced, and in the case of Comparative Example 4, which applied only single hyaluronic acid, a disadvantageous trend may be observed in terms of maintaining moisture for a long time and moisture retention by skin layer. Additionally, in the case of Comparative Examples 2 and 3, which excluded PDRN or ultra-low molecular weight collagen, a reduced trend may be observed compared to the Examples in terms of skin condition recovery and improvement of elasticity indicators. These results support the fact that the combination of dual molecular weight PDRN, ultra-low molecular weight collagen, and the complex of eight types of hyaluronic acid proposed by the present invention contributes to the combined enhancement of skin wrinkle improvement and elasticity strengthening effects compared to simple combination or single-component application.
[0128] Although the present invention has been described above with reference to embodiments, various changes and modifications can be made by those skilled in the art to which the present invention pertains. Such changes and modifications are considered to be within the scope of the present invention as long as they do not depart from the technical concept provided by the present invention. Accordingly, the scope of rights of the present invention should be determined by the claims set forth below.
Claims
Claim 1 A cosmetic composition for improving skin wrinkles based on salmon extract, comprising: purified water 40-75 wt%; butylene glycol 3-12 wt%; glycerin 2-10 wt%; cetearyl alcohol 1-6 wt%; shea butter 1-5 wt%; cetearyl oliveate 0.5-3 wt%; glyceryl stearate 0.5-3 wt%; synthetic beeswax 0.2-3 wt%; palmitic acid 0.2-2 wt%; stearic acid 0.3-2 wt%; PEG-100 stearate 0.3-2 wt%; sorbitan stearate 0.2-2 wt%; polysorbate 60 0.1-1 wt%; ultra-low molecular weight collagen extract 0.1-1 wt%; Centella asiatica extract 0.1-1 wt%; salmon extract 0.01~0.1 wt%; 8-type hyaluronic acid complex 0.05~0.5 wt%; fragrance 0.05~0.3 wt%; and other ingredients composed of a moisturizer, a viscosity modifier, and an emulsifier, wherein the ultra-low molecular weight collagen extract is a collagen extract having an average molecular weight of 200 Da to 300 Da, and the 8-type hyaluronic acid complex comprises sodium hyaluronate, hydrolyzed sodium hyaluronate, hydrolyzed hyaluronic acid, hyaluronic acid, potassium hyaluronate, sodium hyaluronate crosspolymer, hydroxypropyltrimonium hyaluronate, and sodium acetylated hyaluronate, and the 8-type hyaluronic acid complex comprises 0.0125~0.125 wt% sodium hyaluronate; 0.0075~0.075 wt% hydrolyzed sodium hyaluronate; and hydrolyzed hyaluronic acid A salmon extract-based cosmetic composition for improving skin wrinkles, characterized by comprising 0.005~0.05 wt%; hyaluronic acid 0.0075~0.075 wt%; potassium hyaluronate 0.0025~0.025 wt%; sodium hyaluronate crosspolymer 0.0075~0.075 wt%; hydroxypropyltrimonium hyaluronate 0.005~0.05 wt%; and sodium acetylated hyaluronate 0.0025~0.025 wt%. Claim 2 A salmon extract-based cosmetic composition for improving skin wrinkles according to claim 1, wherein the salmon extract is included in the form of sodium DNA, and the salmon extract is composed of a dual molecular weight fraction PDRN comprising a low molecular weight PDRN in the range of 5-50 kDa and a high molecular weight PDRN in the range of 100-1500 kDa, and the low molecular weight PDRN and the high molecular weight PDRN are composed in a weight ratio of 20:80 to 40:
60. Claim 3 delete
Citation Information
Patent Citations
The polynucleotide fragments complex separated from fish's semen or egg and its separating process
KR100986603B1
